Txr1: an important factor in oxaliplatin resistance in gastric cancer.

Bi, Jingtao

Txr1: an important factor in oxaliplatin resistance in gastric cancer. [electronic resource] - Medical oncology (Northwood, London, England) Feb 2014 - 807 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1559-131X

10.1007/s12032-013-0807-1 doi


Adenocarcinoma--drug therapy
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors--genetics
Blotting, Western
Cell Cycle--drug effects
Cell Proliferation--drug effects
Drug Resistance, Neoplasm
Female
Follow-Up Studies
Humans
Immunoenzyme Techniques
Inhibitor of Apoptosis Proteins--genetics
Lymphatic Metastasis
Male
Middle Aged
Neoplasm Staging
Organoplatinum Compounds--therapeutic use
Oxaliplatin
Prognosis
RNA, Messenger--genetics
RNA, Small Interfering--genetics
Real-Time Polymerase Chain Reaction
Repressor Proteins--antagonists & inhibitors
Retrospective Studies
Reverse Transcriptase Polymerase Chain Reaction
Stomach Neoplasms--drug therapy
Survival Rate
Survivin
Tumor Cells, Cultured